Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
7.66
+0.21 (2.82%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $768.78 million as of August 19, 2026. Its market cap has increased by 1,473.40% in one year.
Market Cap
768.78M
Enterprise Value
563.15M
1-Year Change
1,473.40%
Ranking
Category
Stock Price
$7.66
ChartMarket Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has increased from $677.31M to $768.78M, an increase of 13.51%. That is a compound annual growth rate of 2.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 768.78M | 232.85% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 762.98M |
| Crescent Biopharma | 756.29M |
| 4D Molecular Therapeutics | 751.32M |
| Phathom Pharmaceuticals | 749.82M |
| CytomX Therapeutics | 746.31M |
| Cybin | 738.54M |
| Neurogene | 735.42M |
| REGENXBIO | 735.39M |